Related by context. All words. (Click for frequent words.) 68 GSTP1 68 CDKN2A 67 TCF#L# 67 BRAF V#E 67 glutamic acid decarboxylase 67 pathophysiological effects 66 ZNF# 66 PTPN# 66 TCF#L# gene 66 Janus kinase 66 apolipoprotein E4 66 K ras mutations 65 hypermethylated 65 HLA DRB1 65 ABCB1 65 CCR5 delta# 65 susceptibility loci 65 missense mutations 65 SNP rs# [001] 65 LRP5 65 dysbindin 65 rs# [002] 64 Clusterin 64 LRAT 64 TMEM#B 64 chromosome #p# [002] 64 IL#R 64 Angiotensin converting enzyme 64 gene polymorphisms 64 APOL1 64 MLL2 63 PICALM 63 rs# [003] 63 MSH2 63 CC genotype 63 inherited mutations 63 ERBB2 63 APOE ε4 63 variant rs# 63 non mutated KRAS 63 rs# [004] 63 CYT# potent vascular disrupting 63 heterozygotes 63 mutated K ras 63 rs# [001] 63 GSTT1 63 KIAA# 62 MLH1 62 RRM1 62 VCAM 1 62 CDH1 62 HAAH 62 BARD1 62 NNRTI resistance 62 cyclin E 62 UGT#A# * 62 relapsed MM 62 HER2 overexpression 62 protein tyrosine phosphatase 62 allelic variants 62 promoter methylation 62 receptor inhibitor 62 C#Y 62 chromosome #p# [001] 62 LRRK2 gene 62 maternally inherited 62 LPA gene 62 chromosome #p#.# 62 KIF6 gene 62 germline mutations 62 apolipoprotein E 62 histone deacetylases 62 FLT3 62 functional polymorphism 62 genetic polymorphisms 62 KRAS oncogene 62 TGFBR1 * 6A 62 locoregional recurrence 61 rheumatoid factor 61 linkage disequilibrium 61 lactate dehydrogenase LDH 61 Raf MEK ERK 61 JAK2 mutation 61 ORMDL3 61 hepatic lipase 61 IKZF1 61 CDK4 61 HLA DR4 immune 61 causal variants 61 PLX STROKE targeting 61 cagA 61 GPC5 61 sporadic ALS 61 ovarian pancreatic 61 TIMP 1 61 RhuDex ™ 61 EGFR mutations 61 airway hyperresponsiveness 61 CALHM1 61 Multivariate analysis 61 breast carcinomas 61 cell adhesion molecule 61 AGTR1 61 #q# [001] 61 GSTM1 61 STAT4 61 BRAF V#E mutation 61 chromosomal rearrangement 61 ENPP1 61 5 HTTLPR 61 Leydig cells 61 Genetic variants 61 mRNA transcripts 61 SLC#A# [002] 61 Leydig cell 61 subclinical atherosclerosis 61 BRAC2 61 splice variants 61 seropositivity 61 selectively inhibited 61 CNTNAP2 61 Dysregulation 61 atypical hyperplasia 61 genetic variants associated 61 SNP rs# [002] 61 dopamine D4 receptor 61 IDH1 mutation 61 obstructive coronary artery 61 susceptibility gene 61 neurofibrillary 60 SCN5A 60 TEL AML1 60 survival motor neuron 60 Kufs disease 60 MECP2 gene 60 Polymorphisms 60 SMAD4 60 sCJD 60 BRCA2 carriers 60 VKORC1 60 PALB2 60 KRAS mutations 60 HLA DRB1 * 60 ADAM# 60 transthyretin 60 ADPKD 60 HLA B# 60 CYP#C# [002] 60 NPM1 60 multivariate Cox 60 HER2 HER2 60 monogenic 60 GPx 60 Nonalcoholic fatty liver 60 gene polymorphism 60 Yamanaka recipe 60 pool dies unwept 60 MGUS 60 Apolipoprotein E 60 prostate carcinoma 60 5 HT1A receptor 60 GABRA2 60 GBA mutations 60 APOE e4 60 kidney urologic 60 mRNA expression 60 MYH9 gene 60 Leukemias 60 chromosome #q# [001] 60 ADRB2 60 methylation patterns 60 DQB1 * 60 Epstein Barr virus EBV 60 CHD7 60 genetic loci 60 DRB1 * 60 TTR amyloidosis 60 nonalcoholic steatohepatitis NASH 60 isoenzyme 60 KRAS wild 60 antinuclear antibodies 60 receptor tyrosine kinase inhibitor 60 cause cardiac channelopathies 60 E#F# 60 KRAS mutant 60 apolipoprotein E APOE 60 T#I [002] 60 lactate dehydrogenase 60 SE alleles 60 lymph node metastasis 60 GSTM1 gene 60 TYMS 60 familial ALS 60 F#del 60 #q# deletion 60 familial pancreatic cancer 60 methylenetetrahydrofolate reductase 60 LymphoStat B belimumab 60 TNFalpha 60 CREBBP 60 chromosome #q# [002] 60 fronto temporal dementia 60 urate oxidase 60 PIK3CA 60 N acetyltransferase 59 hematopoietic cancers 59 CagA 59 hypomethylation 59 Mutational 59 klotho 59 5 HT2A serotonin 59 HBeAg negative 59 adipogenic 59 LDLR 59 catechol O methyltransferase COMT 59 perilipin 59 pancreatic prostate 59 TNF blocker therapy 59 Amyloid beta protein 59 TRAIL induced apoptosis 59 Chronic pancreatitis 59 HER2 expression 59 chromosome #q#.# [001] 59 FGFR2 59 NKX#.# 59 CFTR cystic fibrosis transmembrane 59 VIPR2 59 TTR gene 59 tumor suppressor protein 59 VLDL cholesterol 59 Epstein Barr Virus EBV 59 DNA methyltransferase inhibitors 59 Subgroup analysis 59 APOE allele 59 MTHFR 59 HLA DR 59 gastric adenocarcinoma 59 β amyloid 59 SLITRK1 59 R#W [002] 59 APOA5 59 ADAMTS# 59 Cystatin C 59 tryptase 59 elevated ALT 59 mutant allele 59 catechol O methyltransferase 59 Fc gamma receptor 59 G6PD 59 MTHFD1L gene 59 GNAQ 59 lung metastasis 59 penetrance 59 Gorlin syndrome 59 V#F mutation 59 Univariate analysis 59 CYP#D# genotype 59 missense mutation 59 studies GWAS 59 DNA methylation patterns 59 NR#A# 59 esophageal squamous cell carcinoma 59 Neuregulin 1 59 TIMP 59 apolipoprotein E gene 59 immunohistochemical 59 APOE4 59 lymphomas leukemias 59 liver histology 59 alanine aminotransferase ALT 59 TRAIL R2 59 EAAT2 59 Xanafide 59 5 lipoxygenase 59 SHANK3 59 IGF binding 59 HER2 positive cancers 59 WDR# 59 autosomal dominant disorder 59 CYP#A# CYP#D# 59 polymorphisms 59 caveolin 59 mGluR5 antagonist 59 pretreatment serum 59 APOE genotype 59 constitutively expressed 59 mutationally activated 59 chromosomal alterations 59 FGFR3 59 Immunohistochemical analysis 59 #p#.# [001] 59 C#T [002] 59 Genetic variation 59 CYP#A# [002] 59 #p#.# [002] 59 herpesviruses 59 Ribavirin causes 59 TMPRSS2 ERG fusion 59 TP# gene 59 maternal serum 59 KIBRA 59 PDGFR 59 inducible nitric oxide synthase 59 Cathepsin B 59 transthyretin TTR 59 coronary calcification 59 ankyrin B 58 thymidylate synthase 58 novel VDA molecule 58 SCN1A 58 homozygotes 58 gene rearrangements 58 INF2 58 KRAS BRAF 58 circulating endothelial cells 58 serum leptin 58 interleukin IL -# 58 Heterozygous 58 neuroblastoma tumors 58 hepatoma 58 EGFR mutant 58 EGFR mutation positive 58 folate metabolism 58 receptor kinase 58 PARP inhibition 58 MDM2 58 CpG rich 58 FUS1 58 III EGFRvIII 58 RNA binding 58 deCODE AF TM 58 NAT2 58 androgen receptor AR 58 HER2 positivity 58 somatostatin analog 58 gene locus 58 Genetic predisposition 58 C. pneumoniae 58 NPM1 gene 58 thyroglobulin 58 TP# mutations 58 LDL receptor 58 frameshift mutation 58 HNPCC 58 MC4R gene 58 RhuDex R 58 #p# [003] 58 1 diabetes T1D 58 poly ADP ribose polymerase 58 eotaxin 58 #q#.# [002] 58 HMGCR 58 #q#.# [001] 58 Cyclin E 58 CISH 58 SETDB1 58 methylation markers 58 interferon beta therapy 58 #q#.# deletion syndrome 58 RUNX3 58 L. pneumophila 58 colorectal adenoma 58 thiopurine 58 PITX2 58 histological subtype 58 anti JCV antibodies 58 causative mutations 58 Upregulation 58 effector function 58 spontaneous mutations 58 Topoisomerase II 58 ATG#L# 58 p# activation 58 #.#ng/ml 58 CD# CD# 58 gamma secretase activating 58 clinicopathological 58 HLA DR4 58 COL#A# 58 p# mutation 58 cystatin C 58 monocytic 58 promoter hypermethylation 58 KRAS variant 58 Macrophage 58 LPS induced 58 HIV coinfected 58 Non Alcoholic Steatohepatitis 58 oligodendrogliomas 58 lymphangiogenesis 58 IL 1Ra 58 tryptophan hydroxylase 58 thyroid peroxidase 58 Rap1 58 IFN ß 58 HLA DQ2 58 ESR1 58 estrogen receptor ER 58 chromosomal regions 58 TMPRSS2 ERG 58 ErbB2 positive 58 Li Fraumeni syndrome 58 Factor Receptor 58 essential thrombocythemia 58 DAT1 58 alpha synuclein gene 58 airway hyper responsiveness 58 autoantibody 58 BMPR2 58 AML MDS 58 ERalpha 58 monozygotic twins 58 IL#B 58 KCNQ1 58 CD# expression [001] 58 humanised monoclonal antibody 58 PKCi 58 ERCC1 58 proto oncogene 58 liver metastasis 58 Oncogenic 58 MnSOD 58 KLF4 58 elevated triglyceride levels 58 wildtype 58 proband 58 Chlamydia psittaci 58 histone deacetylation 58 inhibitory receptor 58 aplastic anemia AA 58 immunohistochemical staining 58 microcephalin 58 2 diabetes T2D 58 allele frequencies 58 Wwox 58 PON1 58 clefting 58 IgG antibody 58 IPAH 58 colorectal carcinoma 58 p# mitogen activated 58 apo E 58 Haptoglobin 58 susceptibility locus 58 invasive lobular 58 euthymic patients 58 estrogen receptor negative 58 miRNA expression 58 basal cell carcinoma BCC 58 APOE gene 58 lipoxygenase 58 CAG repeats 58 breast cancer subtypes 58 visceral adiposity 58 peptide receptor 58 genotype phenotype 58 ABCB1 gene 58 underlying pathophysiology 58 PCR RFLP 58 #p# [001] 57 Vidaza ® 57 SPINK1 57 epithelial tumors 57 NPC1 57 human metapneumovirus 57 Omacetaxine 57 gastric carcinogenesis 57 susceptibility genes 57 EN2 57 epistasis 57 BRCA mutation carriers 57 Karayiorgou 57 dasatinib Sprycel 57 chronic myeloid 57 gastrointestinal stromal 57 Arrhythmogenic Right Ventricular Cardiomyopathy 57 NOTCH1 57 myelofibrosis polycythemia vera 57 advanced adenomas 57 hereditary predisposition 57 chromosomal aberrations 57 1α 57 ERK signaling 57 COX2 57 succinate dehydrogenase 57 osteoprotegerin 57 MetAP2 57 autism susceptibility genes 57 myeloid 57 PsA 57 fatty acid binding 57 chronic eosinophilic leukemia 57 breast cancer genes BRCA1 57 HMGA2 57 hormone receptor negative 57 thymidylate synthase TS 57 Helicobacter pylori infection 57 myeloproliferative neoplasms 57 autoimmune thyroid 57 germline mutation 57 CEACAM1 57 coexpression 57 BRCA1 mutations 57 RASSF1A 57 hormone receptor status 57 rs# rs# 57 progressive neurodegenerative disorder 57 prostate cancer CaP 57 progesterone receptor PR 57 TOP2A 57 Hutchinson Gilford progeria 57 deCODE ProstateCancer TM 57 CYP #D# 57 FGFR4 57 T2 lesions 57 susceptibility alleles 57 Cytochrome P# 57 genotypic 57 underlying vasculopathy 57 immunoblotting 57 JAK2 enzyme 57 IL6 57 thyrotropin 57 microRNA expression 57 metastatic malignant 57 Cyclin D1 57 differentially regulated 57 nephronophthisis 57 transcriptional regulation 57 SGPT 57 retinol binding protein 57 PTEN mutations 57 HER2 HER3 57 homozygote 57 glutamic acid decarboxylase GAD 57 HER2 neu 57 Epigenomics proprietary 57 apolipoprotein B 57 nephrogenic 57 causative mutation 57 apoE 57 Valproic acid 57 multigene expression test 57 related apoptosis inducing 57 calcium calmodulin dependent 57 chromatin immunoprecipitation ChIP 57 Aß 57 baseline LDH 57 clusterin 57 dysbindin gene 57 genotypic resistance 57 chitinase 57 pancreatic lung 57 Immunohistochemical staining 57 causative genes 57 CHRNA5 57 phenotypic expression 57 microdeletion 57 chromosomal anomaly 57 MAGE A3 ASCI 57 HUMIRA resembles 57 Arrhythmogenic 57 TCF4 57 testicular germ cell 57 normal karyotype 57 clinicopathological features 57 neoplasias 57 isotypes 57 PEGylated Fab fragment 57 PCa 57 myeloproliferative disorders 57 HFE gene 57 endocrine therapies 57 latent celiac disease 57 apoE4 57 ALDH2 57 Von Willebrand 57 tumor suppressors cytokines 57 CTAP# Capsules 57 gastric carcinoma 57 formerly LymphoStat B 57 Elevated serum 57 BCL#A 57 bladder carcinoma 57 picomolar 57 aneuploidies 57 T1c 57 aMCI precursor 57 BRCA1 mutation carriers 57 Apolipoprotein E4 57 Autoantibodies 57 Interferon gamma 57 anaphylactic reactions bronchospasm 57 synuclein 57 familial aggregation 57 acute myeloid 57 chromosomal anomalies 57 B Raf 57 advanced adenoma 57 endophenotypes 57 gene amplification 57 quantitative trait loci 57 FMR1 57 cisplatin resistant 57 prognostic marker 57 variant alleles 57 endocannabinoid signaling 57 pDC 57 syngeneic 57 p# mutations 57 BRCA1 BRCA2 57 fluconazole resistant 57 polyglutamate 57 MET amplification 57 atopic asthma 57 haematopoietic 57 methyltransferase 57 pertussis toxin 57 #S rRNA 57 ApoE4 57 dihydrofolate reductase 57 cisplatin gemcitabine 57 tumor xenograft models 57 PTP1B 57 autoantibody positive 57 myeloperoxidase 57 Strong inducers 57 nondemented 57 genetic polymorphism 57 KCNH2 57 paraneoplastic 57 refractory chronic lymphocytic 57 chronic granulomatous disease 57 CHI#L# 57 gene MECP2 57 CYP#B# 57 fibrillin 1 57 alpha folate receptor 57 HLA DRB1 SE 57 Cathepsin S 57 cMET 57 EBV infection 57 mda 7 57 Tasigna prolongs 57 APOC3 57 rifamycins 57 gemcitabine carboplatin 57 MAPK pathway 57 orally administered inhibitor 57 dopamine D2 57 synovial cells 57 JAK2 gene 57 IRF6 57 neuroligins 57 GRNOPC1 contains 57 PON1 gene 57 serous ovarian cancer 56 FLT3 mutations 56 HepG2 cells 56 conductance regulator 56 parkin gene 56 haplotypes 56 oesophageal adenocarcinoma 56 SR B1 56 carcinoembryonic antigen 56 Protein Kinase C 56 tyrosine phosphorylation 56 Hashimoto thyroiditis 56 bronchopulmonary dysplasia BPD 56 p# biomarker 56 node metastases 56 leukemia AML 56 narcolepsy cataplexy 56 HER1 56 microsatellite instability 56 IgA deficiency 56 FasL 56 CIMZIA ™ 56 HG PIN 56 gastrointestinal stromal tumors GISTs 56 PSADT 56 microdeletions 56 CP CPPS 56 multi factorial disease 56 STK# [002] 56 interferon IFN 56 CYP#A# gene 56 hematologic toxicity 56 Meckel Gruber 56 elevated CRP 56 NKG2D 56 cervical carcinoma 56 Beta Amyloid 56 Selective Inhibitor 56 lymphocytic 56 MEF2A 56 haematologic 56 MMP9 56 BRAF mutations 56 aneuploid 56 breast cancer metastasis 56 anaplastic lymphoma kinase 56 Single Nucleotide Polymorphisms SNPs 56 miRNAs miR 56 NPM1 mutation 56 plasma lipid 56 phylogenetic analyzes 56 HOXB# 56 HOMA IR 56 phenotypic variation 56 serine protease 56 GPC3 56 surgically resected 56 Polymorphism 56 histologically confirmed 56 BRCA2 mutation carriers 56 ptau 56 completely resected 56 #q# deletion syndrome 56 NR2B selective 56 Kinoid 56 BRAF gene mutations 56 abnormal p# 56 autosomal recessive disease 56 UGT#B# 56 transgenic rats 56 FCGR3A 56 endostatin 56 CHEK2 56 mitotic catastrophe 56 NSAID induced GI 56 Pharmacokinetic parameters 56 allelic variation 56 Jhdm2a 56 PCA3 gene 56 thrombocytopenic 56 genes predisposing 56 DICER1 gene 56 subclinical hyperthyroidism 56 prognostic factor 56 M. pneumoniae 56 CR nPR 56 #S ribosomal RNA 56 cyclin dependent kinase 56 apoptotic pathway 56 lupus anticoagulant 56 segmental duplication 56 regulator CFTR gene 56 apoC III 56 lobular involution 56 virulence determinants 56 galiximab 56 Folfox 56 adhesion molecule EpCAM expressing 56 C1 INH deficiency 56 downregulated 56 sequence homology 56 intergenic regions 56 nonmetastatic 56 Atypical Hemolytic Uremic Syndrome 56 PKM2 56 selective serotonin 2C receptor 56 E selectin 56 UGT#A# 56 Neisseria 56 Chlamydia pneumoniae 56 FUSILEV enhances 56 Ki# 56 TT genotype 56 EpCAM expression 56 lymphocyte count 56 heterozygous 56 pancreatic endocrine 56 included exfoliative dermatitis 56 ε4 56 metabolizing enzymes 56 T. vaginalis 56 unmutated 56 loci 56 upregulates 56 familial predisposition 56 VNTR 56 histone acetylation 56 BRCA2 mutations 56 cyclooxygenase COX 56 gefitinib Iressa 56 metaplasia 56 COMT gene 56 somatostatin 56 CpG island 56 MYBPC3 56 progranulin gene 56 untreated hypothyroidism 56 virulence genes 56 parathyroid carcinoma 56 PTEN gene 56 mutational status 56 papillary renal cell carcinoma 56 genomewide 56 kinase inhibition 56 leukotriene B4 56 serine threonine kinase 56 proton MR spectroscopy 56 SOD2 gene 56 NPM1 mutations 56 CD#c 56 DRD2 56 neurological manifestations 56 inbred strains 56 EGFR protein 56 FMR1 gene 56 uPA 56 #beta HSD 1 56 differential gene expression 56 mitogen activated protein kinase 56 coinfection 56 Insulin sensitivity 56 etiologic 56 BCG refractory carcinoma 56 protein encoded 56 distant metastasis 56 KCNE2 56 TNF α 56 QTL mapping 56 nonischemic 56 FGFR1 56 NNRTI resistant virus 56 chromosomal mutations 56 siRNA knockdown 56 AAT Deficiency 56 HDL2 56 MC1R 56 Htt 56 intracranial atherosclerosis 56 kidney allograft 56 Soy isoflavones 56 MELAS 56 sphingolipid 56 Epidermal Growth Factor Receptor 56 prognostic markers 56 PDE#A 56 paternally inherited 56 spontaneous mutation 56 gene variants 56 invasive ductal 56 Darapladib 56 WNK1 56 AAT deficiency 56 posttranslational modifications 56 phospholipase A2 56 HLA DR2 56 LHRH receptor positive 56 EGFR mutation status 56 Alleles 56 CSF Tf 56 ALK gene 56 tyrosine kinase receptor 56 ERK1 2 56 certain protein tyrosine 56 homeobox gene 56 PTEN protein 56 μg ml 56 SCHIZOPHRENIA DISORDERS SUPPORT GROUP 56 astrocytomas 56 aspartyl 56 MSMB 56 causative gene 56 coding genes 56 enzyme inhibition 56 atypia 56 AMACR 56 Thiarabine 56 FGFR2 gene 56 lobular carcinoma 56 Septin9 biomarker 56 imatinib Gleevec ® 56 TET2 56 K RAS 56 VHL gene 56 Systemic lupus erythematosus SLE 56 precursor lesions 56 TACI mutations 56 receiving immunosuppressive therapy 56 neoplasm 56 ALK mutations 56 acute humoral rejection 56 hematological parameters 56 SSc 56 renal cell carcinomas 56 NS5B polymerase 56 4E BP1 56 K#R [002] 56 K ras 56 mitochondrial mutations 56 membranous nephritis 56 Monocyte 56 ovarian carcinoma 56 serologically 56 plasma folate 56 LRP6 56 RBP4 56 univariate 56 prostate epithelial cells 56 macrophage migration inhibitory 56 DLX5 56 cervical intraepithelial neoplasia 56 acadesine 56 Peptide YY 55 palladin 55 smoldering myeloma 55 EGFR tyrosine kinase inhibitor 55 IRF6 gene 55 hypophosphatemia 55 hepatocellular carcinomas 55 thyrotropin levels 55 Acute myeloid leukemia 55 mTOR mammalian target 55 actinin 55 CpG 55 FASPS 55 nonnucleoside reverse transcriptase inhibitors 55 Microarray analysis 55 Wnt signaling pathway 55 treat chronic rhinosinusitis 55 uPAR 55 enteroviral 55 Moraxella catarrhalis 55 decarboxylase 55 Immunohistochemistry 55 endogenous ligands 55 vimentin 55 PBMCs 55 p# deficient 55 probands 55 transaminase elevations 55 TSC1 55 tumorigenicity 55 pharmacodynamic biomarkers 55 miR #b [002] 55 modifier genes 55 CCR3 55 inflammatory PDE 55 gamma globin gene 55 monocyte chemotactic protein 55 aminotransferase 55 endothelial activation 55 Estrogen Receptor 55 major histocompatibility complex 55 5 HT2A inverse 55 HER2 receptor 55 activating mutation 55 LRRK2 mutations 55 Azacitidine 55 intraobserver 55 #ß 55 metalloprotease 55 biochemical relapse 55 Wnt#b 55 FDG uptake 55 Letairis ambrisentan 55 endoxifen 55 dysglycemia 55 chemosensitivity 55 Nilotinib 55 selective modulator 55 CYP# [002] 55 sensory neuropathy 55 alpha glucosidase 55 neutrophil elastase 55 immune modulating 55 ara C 55 Belimumab 55 ovarian carcinomas 55 Plasmodium vivax 55 plasma leptin 55 Secretase 55 inverse agonist 55 kDa protein 55 IMiDs ® 55 cytopathic 55 heparanase 55 c KIT 55 kaempferol 55 VEGF expression 55 basal cell nevus syndrome 55 intronic 55 nilotinib Tasigna ® 55 Cryptococcus neoformans 55 HbF 55 BRCA2 mutation 55 murine leukemia virus 55 obesity insulin resistance 55 pyrexia mucositis sepsis febrile 55 cyclin dependent kinase inhibitor 55 dyslipidemia abnormal 55 Systemic lupus erythematosus 55 IGFBP2 55 myeloproliferative diseases 55 epigenetic changes